Strawberry Fields REIT Inc STRW 深 滬
等待開盤 07-18 09:30:00 美东时间
10.14
-0.020
-0.20%
華盛通- 最 高10.35
- 今 開10.15
- 成交量 1.82万股
- 最 低 10.104
- 昨 收 10.16
- 總市值 1.26亿
- 52周最高 12.67
- 市盈率 靜 17.64
- 換手率 0.15%
- 52周最低 8.56
- 委 比 0.00%
- 總股本 1244.51万
- 歷史最高 12.56
- 量 比 0.69
- 振 幅 2.42%
- 歷史最低 4.65
- 每 手 1
- 風險率 0.77%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅336.36%！Canaccord Genuity上调ATAI Life Sciences目标价至12美元，维持"买入"评级
Redburn Atlantic：下调Adobe(ADBE)评级至"卖出"，目标价从420美元降至280美元
07-03 11:01
Compass Point Downgrades Strawberry Fields REIT to Neutral, Lowers Price Target to $10.65
Compass Point analyst Merrill Ross downgrades Strawberry Fields REIT (AMEX:STRW) from Buy to Neutral and lowers the price target from $12.2 to $10.65.
07-02 23:34
Strawberry Fields REIT Expands with Missouri Acquisition
Strawberry Fields REIT Inc ( ($STRW) ) has provided an announcement. On July 1,...
07-02 18:28
Strawberry Fields REIT Acquires Missouri Healthcare Facilities
An announcement from Strawberry Fields REIT Inc ( ($STRW) ) is now available. O...
05-28 20:44
Strawberry Fields REIT reports Q1 results
Strawberry Fields REIT press release (NYSE:STRW): Q1 FFO was $18.3 million and $14.1 million, respectively. AFFO was $16.8 million and $13.1 million, respectively. Net income was $7.0 million and $6.0...
05-09 19:56
Strawberry Fields REIT Q1 Sales $37.33M Beat $32.55M Estimate
Strawberry Fields REIT (AMEX:STRW) reported quarterly sales of $37.33 million which beat the analyst consensus estimate of $32.55 million by 14.70 percent. This is a 34.13 percent increase over sales of $27.83 million
05-09 18:21
Earnings Scheduled For May 9, 2025
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to ...
05-09 16:32
美股大行评级 | 摩根大通：维持Alignment Healthcare"中性"评级，目标价从14美元升至17美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1104689832132448256.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Chardan Capital：维持Ocugen(OCGN)"买入"评级，目标价从6美元升至7美元</p> <p>• Piper Sandler：维持ALX Oncology Holdings(ALXO)"超配"评级，目标
03-07 13:53
美股大行评级 | 富国银行：维持艾伯维"超配"评级，目标价从210美元升至240美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1104327819967434752.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Syndax制药(SNDX)"超配"评级，目标价从35美元升至39美元</p> <p>• 摩根大通：维持AnaptysBio(ANAB)"超配"评级，目标价从36美元升至42美元</p> <p>• 摩根大通
03-06 11:20
Earnings Scheduled For February 27, 2025
Companies Reporting Before The Bell • Hafnia (NYSE:HAFN) is estimated to report...
02-27 16:32
